On January 18, 2018, our Board of Directors (“Board”) appointed Mr. McLaughlin, the Company’s Interim Chief Financial Officer and a member of the Board, to the position of Chief Financial Officer and Treasurer. Mr. McLaughlin was elected as a member of our Board on December 19, 2016 and on March 31, 2017, our Board appointed Mr. McLaughlin as the Company’s Interim Chief Financial Officer.
Mr. McLaughlin is a Certified Public Accountant, licensed in the State of Texas with over 25 years of experience in finance and accounting for small private and large New York Stock Exchange and NASDAQ Stock Market companies. Mr. McLaughlin served as Chief Financial Officer of CPM Medical Consultants, LLC (“CPM”) since 2014. Mr. McLaughlin joined CPM as Vice President Finance, Controller in 2013. From 2006 until he joined CPM, Mr. McLaughlin served as Vice President Finance, Controller for Caris Life Sciences, Inc., $180 million international, anatomic pathology and molecular biotechnology laboratories in a multi-state corporate practice of medicine. Mr. McLaughlin brings strong leadership, record of accomplishment, and considerable broad financial expertise to our Board.